Stockreport

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans [Yahoo! Finance]

Aclarion, Inc.  (ACON) 
PDF Multiple Physicians and Sites Will Enroll in CLUE in the Coming Months Adding Practical Real-world Data to Aclarion's Expanding Body of Clinical Evidence BROOMFIELD, [Read more]